Denali Therapeutics Inc. (MUN:4DN)
19.54
+0.45 (2.33%)
At close: Feb 3, 2026
2.92% (1Y)
| Market Cap | 2.68B -17.9% |
| Revenue (ttm) | n/a |
| Net Income | -425.08M |
| EPS | -2.48 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 30 |
| Average Volume | 100 |
| Open | 19.10 |
| Previous Close | 19.10 |
| Day's Range | 19.10 - 19.54 |
| 52-Week Range | 10.92 - 19.94 |
| Beta | n/a |
| RSI | 63.41 |
| Earnings Date | Feb 27, 2026 |